Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Alembic Pharmaceuticals Limited | Panchmahal, India | Makes it | No problems foundJul 26, 2024 · 8 inspections |
Recalls
- Jul 25, 2025 · Class II · Alembic Pharmaceuticals Limited
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Lots: Lot: 2305015142, Exp. Date: 9/30/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Doxepin: every company that makes it
- Form
- capsule, oral
- Strength
- 50 mg
- Approval
- ANDA ANDA215076
- On the market since
- Apr 23, 2021
- Package NDCs
62332-645-3162332-645-91- Official label
- DailyMed (National Library of Medicine), updated Jul 17, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?